CHM 10.0% 1.8¢ chimeric therapeutics limited

CHM Bell Potter booking building, page-2

  1. 12,295 Posts.
    lightbulb Created with Sketch. 3762

    Dear Steini

    Chimeric Therapeutics Limited (ASX:CHM) is conducting an Entitlement Offer Shortfall Placement comprising of an equity raising of up to $5.5m via the issuance of approximately 196.7m fully paid ordinary new shares at an offer price of A$0.028 which is the same price as the entitlement offer.

    Bell Potter is lead manager to the Placement. Bell Potter is currently conducting a bookbuild for the Placement which you are invited to bid into.

    If you wish to participate in the offer, please send an email outlining your level of demand to Bell Potter contacts Daniel Goodman ([email protected]) and Dermott Wilson ([email protected]) by 9:30am AEDT tomorrow, 17th January 2024.

    Please see the link at the button below which outlines full details of the Offer. If you have any questions, please contact Dermott or Daniel at the details above.

    Kind regards

    Paul Hopper
    Executive Chairman

    Jennifer Chow
    Managing Director & CEO



    BP Deal Sheet - Template (mcusercontent.com)



 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.8¢
Change
-0.002(10.0%)
Mkt cap ! $15.52M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $11.17K 599.2K

Buyers (Bids)

No. Vol. Price($)
10 1125108 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1462067 5
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.